Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » Taxes

This excerpt taken from the EYE 8-K filed Oct 31, 2008.

Taxes

 

  •  

Reported $4.3 million provision, representing an approximate 38% effective tax rate.

This excerpt taken from the EYE 8-K filed Aug 4, 2008.

Taxes

 

  •  

Reported $13.5 million provision, representing an approximate 38% effective tax rate.

This excerpt taken from the EYE 8-K filed May 1, 2008.

Taxes

 

  •  

Reported $4.2 million provision, representing an approximate 38% effective tax rate.

This excerpt taken from the EYE 8-K filed Apr 3, 2007.

6.11 Taxes.

The Borrower and its Subsidiaries have timely filed all Federal tax returns and all material state, local and foreign tax returns and reports required to be filed, and have duly and timely paid all Federal, state and other material taxes, assessments, fees and other governmental charges levied or imposed upon them or their properties, income or assets otherwise due and payable or for which they otherwise would be liable, except those which (i) are being contested in good faith by appropriate proceedings diligently conducted and for which adequate reserves have been provided in accordance with GAAP and (ii) could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There is no proposed tax assessment, deficiency or audit against the Borrower or any Subsidiary that could reasonably be expected to have a Material Adverse Effect.

EXCERPTS ON THIS PAGE:

8-K
Oct 31, 2008
8-K
Aug 4, 2008
8-K
May 1, 2008
8-K
Apr 3, 2007

RELATED TOPICS for EYE:

"Taxes" elsewhere:

Boston Scientific (BSX)
ABIOMED (ABMD)
Antares Pharma (AIS)
MGC DIAGNOSTICS Corp (ANGN)
AngioDynamics (ANGO)
Bovie Medical (BVX)
Cantel Medical (CMN)
Cooper Companies (COO)
Conceptus (CPTS)
Haemonetics (HAE)
ICU Medical (ICUI)
West Pharmaceutical Services (WST)
DENTSPLY International (XRAY)
Young Innovations (YDNT)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki